• 6
    Mar
    A female Dr making notes at a desk

    NICE publishes technology appraisal guidance on Casgevy

    On February 9, 2024, the European Medicines Agency (EMA) issued a marketing authorisation for eExagamglogene autotemcel (Casgevy, by [...]

    0 Comments

  • 25
    Nov
    A graphic that says ISPOR Europe 2024 in a blue circle

    Post ISPOR – Navigating the new joint clinical assessment process

    During ISPOR we heard that the Joint Clinical Assessment (JCA) aims to enhance the quality of [...]

    0 Comments

  • 23
    Nov
    A graphic of AI in medicine

    Post-ISPOR: Use of generative AI in healthcare

    As the use of generative AI becomes more common, there is a growing need to understand [...]

    0 Comments

  • 8
    Oct
    A graphic of French and English flags talking

    Va-t-on vers NICE ? / Are we heading towards NICE?

    La réforme de la Commission d’évaluation économique et de santé publique, va-t-on vers NICE ? / [...]

    0 Comments

  • 17
    Sep
    A graphic of a map of Europe

    Harmonizing Health Technology: The EU’s Joint Clinical Assessment

    The Joint Clinical Assessment (JCA) is a significant initiative within the European Union’s Health Technology Assessment [...]

    0 Comments

  • 10
    Sep
    Natalie Shalet and her mother

    A Personal Reflection: 15 Years Later

    It’s been 15 years and two days since my mother passed away from non-small cell lung [...]

    0 Comments

  • 5
    Sep
    A screenshot of the article about using Risankizumab to treat Ulcerative Colitis, on the NICE website

    NICE Recommends Risankizumab for Ulcerative Colitis

    The National Institute for Health and Care Excellence (NICE) has issued technology appraisal guidance on the [...]

    0 Comments

  • 22
    Aug
    A map of reported Mpox cases as reported by the Centers for Disease Control (CDC) as of 6th August 2024

    Navigating the Mpox Crisis

    Navigating the Mpox Crisis: Lessons from COVID-19 and the Road to Effective Therapeutics Introduction: On August [...]

    0 Comments

  • 21
    Aug
    A bar chart illustrating measurement of biopharmaceutical R&D investment

    Comprehensive measurement of biopharmaceutical R&D investment

    Thoughts on a recent publication: Comprehensive measurement of biopharmaceutical R&D investment The recently released study, “Comprehensive [...]

    0 Comments

  • 25
    Apr
    Natalie Shalet at World Orphan Drug Congress 2024

    Changes to the EU General Pharmaceutical Legislation

    Changes to the EU General Pharmaceutical Legislation – will Europe still be competitive? During the #worldorphanusa [...]

    0 Comments